Latest Strategy News

Transurban Group's March quarter 2026 traffic update shows a 3.0% increase in average daily traffic, supported by new infrastructure openings in Melbourne and North America amid ongoing macroeconomic and geopolitical challenges.

Lefroy Exploration Limited (ASX: LEX) reports encouraging grade control drilling results and successful initial gold production from its Lucky Strike Gold Mine in Western Australia, supporting resource growth and ongoing mining operations.

Elevate Uranium Ltd has reinforced its U-pgrade™ Pilot Plant operations in Namibia with new management and process improvements, while revising its timeline for pilot plant results to August 2026. The company confirms previous bench-scale testwork remains valid despite the delay.

Condor Energy has agreed to acquire Jaguar Exploration’s 20% stake in the TEA 86 offshore Peru project, moving to full ownership. The deal, structured through performance shares, aims to simplify equity and support licence conversion and future partnerships.

Electro Optic Systems Holdings Limited (ASX: EOS) has concluded its civil penalty proceedings with ASIC, agreeing to a $4 million penalty and costs. This resolution marks a significant step in addressing legacy issues and refocusing on strategic growth.

Regener8 Resources NL Ltd (ASX:R8R) has revised its pro rata non-renounceable rights issue, offering new shares at $0.10 each to eligible shareholders across five jurisdictions. The offer aims to raise up to $2.87 million before costs, with further details due in early April.

Critical Resources Limited has initiated ground exploration at its Lammerlaw and Croesus projects in New Zealand, focusing on historically significant gold, antimony, and tungsten mineralisation. The company highlights exceptional historic tungsten grades up to 42.6% WO3 and a multi-kilometre gold-antimony trend, with initial results expected in the coming months.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Tamboran Resources Corporation has initiated an underwritten public offering of nearly 3 million shares to support expanded drilling and resource delineation in the Beetaloo Basin, alongside a concurrent institutional entitlement offer.

TZ Limited (ASX:TZL) has secured $0.81 million through a private placement at a 22% premium to the last traded price, issuing 16.2 million shares with attaching options pending shareholder approval. The funds will support debt repayment, vendor payments, working capital, and growth initiatives in smart locking and data centre security.

Resolution Minerals Ltd has secured FAST-41 status for its Antimony Ridge project in Idaho, a designation expected to accelerate permitting and development of this critical minerals asset. The move supports the company's integrated U.S. strategy for antimony, tungsten, and gold, enhancing investor visibility and strategic engagement.

Greenwing Resources has initiated a scoping study at its 100%-owned San Jorge Lithium Brine Project in Argentina, appointing lithium brine specialist Zelandez to lead the work. The study aims to define development pathways and an economic framework for the project, which hosts a maiden Mineral Resource Estimate of 1.07Mt LCE.